Back to All Events

Single Circulating Vesicle Analysis for Early Cancer Detection

Single Circulating Vesicle Analysis for  Early Cancer Detection

Friday, February 4, 2022

3-4pm EST

Join the Zhu Family Center and the DF/HCC Cancer Risk, Prevention and Early Detection (CaRPED) program on February 4, World Cancer Day 2022, for a virtual seminar entitled “Single Circulating Vesicle Analysis for Early Cancer Detection,” presented by Ralph Weissleder, MD, PhD, Center for Systems Biology, Massachusetts General Hospital, Department of Systems Biology, Harvard Medical School.

Exosomes and other circulating extracellular vesicles (EV) in peripheral blood have emerged as potential biomarkers for cancer. There are now over 5,000 publications per year on EVs but their utility in early cancer detection remains largely unknown. This presentation will review the background, technical capabilities of different assays and theoretical considerations to enable early cancer detection.

FEATURING 
Ralph Weissleder, MD, PhD, Center for Systems Biology, Massachusetts General Hospital, Department of Systems Biology, Harvard Medical School

MODERATOR
Tim Rebbeck, PhD, Director, The Zhu Family Center for Global Cancer Prevention; Vincent L. Gregory Jr. Professor of Cancer Prevention, Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute; Associate Director for Equity and Engagement, Dana-Farber/Harvard Cancer Center

For more information contact the Zhu Center at cgcp@hsph.harvard.edu

Previous
Previous
January 28

Data integration from multiomics to imaging

Next
Next
February 15

Semiconductor Technology Translation and Hard-Tech Startups